Skip to content

Prospective clinical study of minimally invasive surgery with Da Vinci robot for laryngopharyngeal tumors

Prospective clinical study of minimally invasive surgery with Da Vinci robot for laryngopharyngeal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037770
Enrollment
Unknown
Registered
2020-09-03
Start date
2020-11-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal cancer, laryngopharyngeal cancer

Interventions

Case series:Da Vinci robotic surgery

Sponsors

Department of Ophthalmology, otolaryngology affiliate to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with good tumor exposure; 2. Patients with non vascular benign tumors in oropharynx, larynx, laryngopharynx and pre styloid space; 3. T1, T2 and T3 / T4A patients with oropharyngeal, laryngeal and hypopharyngeal malignancies; 4. Preoperative imaging examination showed that there were no patients with internal carotid artery, common carotid artery, skull base, mandible, hard palate, thyroid cartilage, cricoid cartilage, anterior vertebral fascia, etc; 5. The patients with no distant metastasis were found in general examination; 6. Patients without contraindication of general anesthesia; 7. The patients were informed and agreed with tors and agreed to open surgery for tumor resection if necessary.

Exclusion criteria

Exclusion criteria: 1. Subjects with limited mouth opening; 2. Patients with unresectable cervical lymph node metastasis; 3. Patients who need to resect more than 50% of the tongue base and pharyngeal wall; 4. Patients with severe cervical spondylopathy with difficulty in supination; 5. Patients with contraindications of general anesthesia; 6. Patients who can't tolerate choking after tongue base and laryngeal surgery; 7. Patients with distant metastasis.

Design outcomes

Primary

MeasureTime frame
Survival time;

Secondary

MeasureTime frame
operation time;Bleeding volume;complication;Hospital stay;Surgical margin;

Contacts

Public ContactLiang Zhou

Department of Ophthalmology, otolaryngology affiliate to Fudan University

zhoulent@126.com+86 13801652474

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026